Clinical Trial Update: Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER [Phase 3]

View source ↗

Summary

This clinical trial update reports termination of an extended access program evaluating the long-term safety of bardoxolone methyl in patients with pulmonary hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Bardoxolone Methyl (bardoxolone methyl)

Snippet

Sponsor: Biogen | Conditions: Pulmonary Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2023-10-12